FoundMyFitness · 2026-03-24 · Rhonda Patrick (host), Arthur Brooks

How To Build Lasting Happiness | Dr. Arthur Brooks

48 research-tied claims examined: 8 contradicted 1 contradicted online 11 overstated 2 context 19 supported 2 corroborated online 5 unverified

8

Contradicted by research

0:00:00Arthur Brookscontradictedmoderate

There is more brain space and tissue devoted in the limbic system to negative emotions than to positive emotions.

"You know, there's literally more space in the brain, more tissue devoted in the limbic system to negative emotions than to positive emotions." (said at 0:00:00)

The claim that there is "literally more space in the brain" or more tissue in the limbic system dedicated to negative emotions than positive emotions is contradicted by neuroimaging evidence. Large-scale neuroimaging meta-analyses demonstrate that the brain does not possess segregated anatomical structures or distinct volumes of tissue dedicated separately to positive versus negative emotions. Instead, positive and negative affect recruit a flexible, shared network of valence-general limbic and paralimbic regions. While behavioral and psychological research recognizes a "negativity bias" (where negative stimuli often elicit stronger cognitive or physiological attention), this reflects functional processing dynamics rather than a greater anatomical volume or dedicated tissue allocated to negative emotions in the limbic system.

0:06:09Arthur Brookscontradictedmoderate

The prefrontal cortex constitutes 30% of the human brain by weight.

"the prefrontal cortex, the bumper of tissue behind your forehead. That's 30% of your brain by weight, the supercomputer." (said at 0:06:09)

Volumetric and morphometric neuroanatomical measurements show that the prefrontal cortex constitutes approximately 10% to 13% of total human brain volume (measured at 12.5% in comparative MRI studies), not 30%. The frequently cited figure of roughly 25% to 30% refers specifically to the proportion of the cerebral cortex (or cortical gray matter), rather than the weight or volume of the entire brain.

0:21:32Arthur Brookscontradictedmoderate

Most Olympic athletes who win a medal experience clinical depression in the wake of winning.

"Most Olympic athletes who win a medal have a have a have a clinical depression in the wake of winning an Olympic medal." (said at 0:21:32)

While qualitative research describes a transient psychological letdown or anticlimax following major competitions (often termed the "post-Olympic blues"), empirical evidence contradicts the claim that a majority (>50%) of Olympic medalists develop clinical depression. Systematic reviews and meta-analyses assessing elite athletes demonstrate that the prevalence of self-reported anxiety and depressive symptoms among active elite athletes is approximately 34% (comparable to non-athlete populations), and the rate of formal clinical major depressive disorder is substantially lower, with no evidence that winning an Olympic medal induces clinical depression in most competitors.

0:40:48Arthur Brookscontradictedmoderate

More brain tissue in the limbic system is dedicated to negative emotions than to positive emotions.

"There's literally more space in the brain, more tissue devoted in the limbic system to negative emotions than to positive emotions." (said at 0:40:48)

The claim that there is literally more space or brain tissue in the limbic system devoted to negative emotions than to positive emotions contradicts large-scale neuroimaging evidence. Meta-analyses of human neuroimaging (fMRI/PET) studies show that emotional valence is not segregated into distinct anatomical territories where negative emotions occupy larger anatomical volumes of tissue. Instead, comprehensive meta-analyses (e.g., Lindquist et al., 2016, analyzing 397 neuroimaging studies and 6,827 participants) demonstrate that positive and negative affect recruit a shared, flexible set of valence-general limbic and paralimbic brain structures rather than separate, anatomically partitioned tissue areas.

1:36:00Arthur Brookscontradictedmoderate

Casual physical touch in men increases oxytocin and vasopressin levels.

"And there's a lot of sort of contested theories about actually how this works. But for sure there's more oxytocin, but there's more vasopressin, which is defense and strength." (said at 1:36:00)

The speaker claims that casual physical touch in men increases both oxytocin and vasopressin levels. While physical touch or massage can increase oxytocin under certain conditions, clinical research evaluating tactile interventions (such as Swedish massage and light touch) shows a decrease in circulating arginine-vasopressin (AVP) levels rather than an increase. Specifically, a randomized study comparing massage therapy and light touch observed a significant decrease in circulating AVP levels following tactile interventions (PMID 20809811, PMID 22775448). Therefore, the claim that physical touch increases vasopressin is contradicted by available human trial evidence.

1:39:12Arthur Brookscontradictedhigh

Women naturally have more developed right cerebral hemispheres, whereas men have more developed left cerebral hemispheres.

"Women are better at this in no small part because women naturally have more developed right hemispheres of the brain... Men have generally more developed left hemispheres of their brain, which is why little boys like trains." (said at 1:39:12)

The claim that women naturally have more developed right cerebral hemispheres and men more developed left hemispheres is contradicted by modern neuroimaging evidence. Large-scale structural MRI meta-analyses (such as the ENIGMA consortium study of 17,141 individuals) and structural brain mapping show population-level patterns of hemispheric asymmetry (such as thicker left cortex and larger right surface area) across both sexes, with subtle regional variations rather than whole-hemisphere dominance by sex. Brains exhibit a mosaic of features with substantial individual overlap rather than dimorphic hemispheric development where one sex develops one hemisphere more than the other.

1:39:50Arthur Brookscontradictedmoderate

Simon Baron-Cohen's autism research associates autism with hyper-development of the left cerebral hemisphere, explaining its higher prevalence in boys.

"Simon Baron-Cohen... He teaches at Cambridge. He does really, really important work on this, and his work touches on hemispheric lateralization, the hyper-development of the left hemisphere of the brain, which is associated with autism. It's just one of the reasons it's more prevalent in little boys than it is in little girls." (said at 1:39:50)

The speaker reverses the direction of hemispheric lateralization described in autism neurobiology and Simon Baron-Cohen's research. Baron-Cohen's work centers on the 'extreme male brain' and 'empathizing-systemizing' theories of autism, linking elevated prenatal testosterone to a shift toward systemizing cognitive profiles. In neuroimaging and lateralization research, including studies co-authored by Baron-Cohen's group, autism is consistently associated with reduced leftward asymmetry (or left-hemisphere dysfunction) and atypical rightward lateralization—not hyper-development of the left hemisphere.

1:37:19Arthur Brookscontradictedmoderate

All euphoric substances are neurotoxic.

"And part of the reason I don't recommend that is that all euphoric substances are neurotoxic. That's the rule." (said at 1:37:19)

The absolute claim that 'all euphoric substances are neurotoxic' is contradicted by pharmacological and toxicological evidence. While several recreational substances that produce euphoria (such as methamphetamine, synthetic cathinones, and high-dose MDMA or alcohol) exhibit well-documented neurotoxic mechanisms—such as oxidative stress, mitochondrial damage, and monoaminergic terminal degeneration—neurotoxicity is not an inherent or universal property of all euphoric compounds. Multiple substances capable of inducing euphoria, such as classical psychedelics (e.g., psilocybin, LSD) and certain opioids (e.g., morphine), do not cause direct neuronal cell death at physiological or therapeutic doses and have even demonstrated neuroplastic, anti-inflammatory, or neuroprotective properties in preclinical models.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.